Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Oct 23, 2020
Technical advances towards the industrial application of transaminases for the synthesis of chiral amines
Read more
Scientific Article
Scientific Article
/ Jan 24, 2019
New crystalline forms of vilanterol trifenatate and processes for their preparation
Read more
Scientific Article